Bioceltix sp. z o.o.

Recent Finacing

Non-Equity

Recent Raise

$2.8M

Bioceltix develops allogeneic stem cell–based medicinal products for companion animals and is advancing a canine atopic dermatitis candidate in a multicenter double‑masked clinical trial across 20 European clinics.